Page last updated: 2024-08-22

carbendazim and Colorectal Neoplasms

carbendazim has been researched along with Colorectal Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Higa, AT; Jacobs, AT; McAllister, HA; Taylor, FR; Wales, CT1
Camden, JB; Davidson, K; Hammond, LA; Izbicka, E; Lawrence, R; Von Hoff, DD; Weitman, S1

Other Studies

2 other study(ies) available for carbendazim and Colorectal Neoplasms

ArticleYear
ERK-dependent phosphorylation of HSF1 mediates chemotherapeutic resistance to benzimidazole carbamates in colorectal cancer cells.
    Anti-cancer drugs, 2015, Volume: 26, Issue:6

    Topics: Antineoplastic Agents; Benzimidazoles; Carbamates; Cell Line, Tumor; Colorectal Neoplasms; DNA-Binding Proteins; Drug Resistance, Neoplasm; Heat Shock Transcription Factors; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nocodazole; Phosphorylation; Transcription Factors

2015
Exploring the mechanisms of action of FB642 at the cellular level.
    Journal of cancer research and clinical oncology, 2001, Volume: 127, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzimidazoles; Breast Neoplasms; Carbamates; Cell Cycle; Cell Division; Colorectal Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Genes, p53; Humans; Leukemia; Leukemia, Experimental; Male; Melanoma, Experimental; Mice; Neoplasm Proteins; Ovarian Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2001